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INTRODUCTION 
Surgery produces both visceral and somatic pain. This results in 
the release of nociceptive substances such as prostaglandins, histamine, 
serotonin, bradykinnin, 5-hydroxytryptamine, substance P and 
generation of noxious stimuli that are transduced by nociceptors and 
transmitted by A delta and C nerve fibres to the neuraxis.  
Pain is the most important factor responsible for ineffective 
ventilation, ineffective cough, and impaired ability to sigh and breathe 
deeply, in patients after upper abdominal surgery. This may contribute to 
pulmonary atelectasis   leading to ventilation/perfusion abnormalities 
and hypoxemia, as well as infection, after surgery .  
 
Many of these adverse effects can be eliminated or reduced  by 
adequate post operative  pain relief. Several methods have been 
advocated to reduce  postoperative pain.  
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The administration of local anesthetics into the pleural space is a 
technique of providing analgesia of rapid onset and long duration. This 
analgesia is accomplished without causing the respiratory depression or 
sedation associated with the use of opioids.   
 
This study is chosen to investigate the efficacy of  interpleural 
analgesia in treating postoperative pain . 
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AIM OF THE STUDY: 
 
 
This study intends to prospectively analyze the efficacy of 
interpleural analgesia in reducing post operative pain and parenteral 
analgesic requirement in patients undergoing upper abdominal surgery.   
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PHYSIOLOGY OF PAIN 
Pain impulses from most of the abdominal and thoracic viscera are 
conducted through afferent fibers that travel with the sympathetic 
nervous system. Impulses from structures deep in the pelvis are 
transmitted via the sacral parasympathetic nerves. 
Pain receptors in the viscera are similar to those in the skin but 
more sparsely distributed. Any event that causes stimulation of nerve 
endings in the viscera produces diffuse, poorly localized pain and often 
associated with nausea and signs of autonomic nervous system 
activation. 
Visceral pain typically radiates and may be referred to surface 
areas of the body with the same dermatomal origin. Visceral pain 
initiates reflex contraction of the nearby skeletal muscles which make 
the abdominal wall rigid when the inflammatory processes involve the 
peritoneum. 
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Somatic pain is described as sharp, stabbing, well localized pain 
that typically arises from the skin, skeletal muscles and peritoneum. Pain 
from surgical incision and peritoneal irritation is somatic pain. This pain 
is transmitted via the spinal nerves. 
Further transmission is determined by complex modulating 
influences in the spinal cord. Some impulses pass to the anterior and 
anterolateral horns to provoke segmental reflex responses. Others are 
transmitted to higher centers via the spinothalamic and spinoreticular 
tracts, where they produce   suprasegmental and cortical responses. 
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Factors affecting clinical pain. 
 
There are many factors affecting the variablity of clinical pain 
complaint, behaviours and response to management. These include 
biological factors, psychological factors ,social/ environmental factors 
pharmacological factors . 
Biological factors.                       
1. Sensitization of  peripheral and central  nociceptors  in response to 
prolonged noxious stimuli so amplifying  the subsequent response.              
2. Modulation or dampening of nociceptors at various points of their 
passage to conciousness. 
3. Eliciting motor or autonomic reflexes 
Psychological  factors 
1. Affective :  emotional response to pain is influenced by preexisting 
affective dysfunction and personality traits 
2. Cognitive : Understanding the nature, cause, purpose and 
consequences of the pain, together with learned influences . 
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Social and environmental factors  
The gain derived from an individuals interaction with family, 
work, community and health carers together with immediate context. 
Pharmacological factors 
 Individual’s pharmacokinetic and   pharmacodynamics   variability. 
 
Effects of postoperative   pain on various systems. 
 
Effects on respiratory  system. 
Surgery involving upper abdomen and thorax produce number of 
pulmonary changes. They   include reduced vital capacity, tidal volume, 
residual volume, functional residual capacity and forced expiratory 
volume. The greatest reduction is in the total lung capacity. Decrease in 
forced vital capacity upto 50% on first day of abdominal   surgery. 
Surgical incision involving the upper abdomen decreases the 
diaphragmatic function resulting in reduced pulmonary compliance, 
muscle splinting, inability to breathe deeply or cough forcefully and in 
some cases may even cause hypoxemia and hypercarbia. Surgeries 
involving lower abdomen may cause less marked effect on respiration. 
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Effects on cardiovascular system. 
Pain causes sympathetic stimulation resulting in tachycardia, 
increased stroke volume, increased cardiac work and increased 
myocardial oxygen consumption. This coupled with hypoxemia results 
in increased risk of myocardial ischemia or infarction in potential 
subjects. Also  decreased ambulation due to pain leads to venous stasis, 
increased risk of deep vein thrombosis and pulmonary embolism. 
 
Effects on Neuroendocrine and metabolism 
A lot of effort is being taken to reduce the stress response during 
surgery. But post operative pain leads to suprasegmental reflex response 
resulting in hypothalamic stimulation, increased sympathetic tone ,an 
increased catecholamine and catabolic hormone secretion (ACTH, ADH, 
Glucagon, CAMP, Renin, Angiotensin II ) and decreased anabolic 
hormones like insulin. These responses collectively result in sodium and 
water retention, hypoglycemia and increased free fatty acid levels, 
ketones and lactate. This is further worsened by reflex muscle spasm 
causing increased oxygen   demand and lactate production. Thus a 
catabolic state and negative nitrogen balance ensues. 
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Effects on  Gastrointestinal system and urinary system. 
Pain causes parylitic ileus, nausea, vomiting and urinary retention. 
Severe postoperative pain causes increased morbidity and mortality. 
Effective analgesia results in decreased incidence of respiratory 
complications, decreased incidence of cardiovascular complications, 
early return of GIT activity, early ambulation and early discharge from 
the hospital. 
Postoperative pain relief is necessary for patient comfort, and to 
facilitate ventilation and ambulation. Upper abdominal surgery, 
including   cholecystectomy, induces alterations of pulmonary function. 
Parenteral opioids which are used extensively for postoperative 
analgesia are associated with undesirable side effects. These   include 
hypoxic episodes while the patient is asleep and incomplete and sporadic 
analgesia. The use of   opioid   analgesia, either   intravenously, 
intramuscularly, or intraspinally  can cause respiratory depression.  
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Methods of postoperative pain  relief. 
The various methods of post operative pain relief are 
A. Opiates 
     1.Intramuscular 
      2.Intravenous  
     3.Intradural/ Extradural 
    4. Patient controlled analgesia (PCA) 
     5.Other routes :oral, transmucosal,  transdermal and rectal. 
B. Non opiates 
 Invasive  
1. Local anaesthesia 
2. Regional anaesthesia 
3. Cryoanalgesia 
4.  Continuous intrapleural infusion 
Noninvasive 
     1.Inhalational 
     2.Transcutaneous electrical nerve stimulation(TENS) 
     3.Hypnosis 
    4.Electroacupuncture 
    5.Relaxational techniques. 
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REVIEW OF LITERATURE 
 
Interpleural instillation of local anaesthetic solutions was 
originally described in 1984 by Kvalheim and Reiestad (1) for 
postoperative pain relief. Since then, interpleural analgesia has been   
shown to be effective for postoperative pain management in patients 
undergoing cholecystectomy, breast surgery, and renal surgery with 
remarkably low blood levels of local anaesthetic achieved. (2-4) 
  
Rocco and Reiestad have shown the efficacy of interpleural 
analgesia in patients with multiple rib fractures and flail chest(5). 
Reiestad and Kvalheim found the technique effective in treating  severe 
acute and  subacute thoracic herpes zoster, perhaps even  preventing the 
development of chronic post-herpetic neuralgia.(6) Recently the 
interpleural catheter technique has been shown to be effective in the 
treatment of various chronic pain conditions.(7,8) 
Interpleural analgesia produces regional analgesia of the chest wall  
 
and is used for pain therapy of different indications which include  
 
breast, renal, gall bladder and thoracic surgery, and chronic  
 
pain(9). 
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The effect of interpleural analgesia on postoperative hospital 
course was analyzed in a prospective randomized study   by Frank et al 
(10) of patients undergoing   cholecystectomy .  
 
In their study, control patients were treated in the standard manner 
with systemic narcotics alone; catheter patients had an interpleural 
catheter placed at the end of surgery and, in addition, could receive 
systemic narcotics if necessary. Pain score, pulmonary function and 
narcotic requirement were measured over the first postoperative day. 
Catheter patients had a lower average pain score (visual analog scale 
(VAS), 3.6 versus 5.2), decreased narcotic requirement in the recovery 
room and improved oxygen saturation (96% versus 93%). However, 
there was no statistical difference in amount of morphine (catheter, 25 ± 
14 mg; control, 31 ± 15 mg), number of narcotic injections. 
In another study by Luc Frenette et al (11) Forty-two patients 
undergoing elective cholecystectomy were randomly assigned to two 
groups: one to receive interpleural administration of bupivacaine-
adrenaline mixture (Group I = 22 patients) and the other standard 
administration of intramuscular meperidine (Group 2 = 20 patients) for 
postoperative pain relief. This study concluded  that the interpleural 
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analgesia can achieve better pain relief with greater ventilatory capacity 
than a standard analgesic regimen in the first two days after surgery. 
In a double-blind, randomized control trial comparing 
intraperitoneal versus  interpleural morphine or bupivacaine for pain 
after laparoscopic  cholecystectomy  by Schulte et al(12), interpleural  
bupivacaine (0.25%) produces adequate  analgesia after  laparoscopic 
cholecystectomy. the lack of effect of intraperitoneal injections was  
attributed to the small dose and to a rapid dilution within the peritoneal 
cavity. Interpleural morphine (0.005%) group  was  ineffective  due to an 
intact perineurial  barrier in the noninflamed pleural cavity, which 
restricts the transperineural passage  of morphine to opioid receptors on 
intercostal nerves. 
In the current literature there are publications providing evidence 
both supporting and opposing the effectiveness of the postoperative pain 
management via IP analgesia after thoracotomy. An explanation for 
insufficient pain reduction may be the loss of local anesthetics in the 
chest tubes and altered diffusion within the parietal pleura after 
mechanical irritation by the surgical procedure. A dilution of the local 
anesthetics by pleural exudation appear to play a subordinate role 
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because we could not demonstrate a relationship between chest tube 
fluid loss and analgesic requirement or pain scores. 
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Anatomy of pleural cavity 
Each lung is covered with a smooth glistening layer of visceral 
pleura except on the medial surface where the structures in the root of 
the lung are continous with the mediastinum. Here the visceral pleura 
which surrounds the root is continous with the parietal pleura which 
covers the surface of the mediastinum (mediastinal pleura). The pleura 
which surrounds the root of the lung extends inferiorly as a narrow fold 
called pulmonary ligament.  
The mediastinal pleura is continous with the other parts of the 
parietal pleura. 
(1) Anteriorly and posteriorly with the costal pleura which lines 
the thoracic wall. 
(2) Inferiorly, with diaphragmatic pleura which covers the 
anterior surface of the diaphragm lateral to the 
mediastinum. 
(3) Superiorly, with the dome of the pleura which extends 
through the superior aperture of the thorax into the root 
of the neck. 
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  Anatomy of pleural space 
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The diaphragmatic  pleura  and the dome of the pleura are 
continous with the costal pleura respectively at the margins of the 
diaphragm and the first rib. 
The parietal pleura  differs from the visceral pleura in having a 
thick fibrous layer (Endothoracic fascia)   externally. 
 
Dome of the pleura 
 Dome of the pleura bulges into the root of the neck from the 
interanal margins of the first rib .The right and left dome of pleura  are 
separated by the midline structures (trachea and esophagus) and the 
blood vessels passing to and from the neck . 
The subclavian vessels arch over the anterior surface of the dome, the 
artery near its highest point and the vein anteroinferior to the artery. The 
internal thoracic artery descends on the front of the dome from the 
subclavian artery to the back of the first costal cartilage. Between these 
two structures and the dome is a layer of dense fascia (Suprapleural 
membrane ) which spreads from the transverse process of seventh 
cervical vertebra to the internal margin of first rib. 
Parenchyma of the lung and visceral pleura are insensitive to pain. 
Nevertheless the bronchi and parietal pleura are very sensitive to pain. 
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Pleural recesses 
These are the parts of the pleural cavity which are not occupied by 
the lung except in full inspiration . 
The costomediastinal recess lies along the anterior margin of the 
pleura. 
The costodiaphragmatic recess extends inferiorly between the 
thoracic wall and the lateral and posterior parts of the diaphragm. 
Deep in the recess , where the costal and the diaphragmatic parts 
unite they are bound down to the costal  cartilages and diaphragm 
by a narrow thickening of endothoracic fascia (phrenicopleural 
fascia) 
The potential space between these two layers is the pleural cavity. Under 
normal conditions the two surfaces are in opposition except for a small 
quantity of lymph which acts as a lubricant. 
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Surface Anatomy 
 The surface anatomy of pleura is as follows. The apex of 
the pleura  project 2 to 3 cms above the clavicle at the  apex of the 
pleural cavity outer surface is surrounded by loose areolar tissue(Sibsons 
fascia) in which small fibrous bands can sometimes be demonstrated 
coursing over the dome of the lung (Bands of Sebalot). From the apex 
the pleura descends medially meeting in the midline at the second costal 
space or sternal  angle. From the sternal angle pleura descends down till 
the 4th costal cartilage on both the sides. From here onwards in the right 
side pleura continues medially till the 6th costal cartilage. In the left side 
it deviates laterally from the 4th costal cartilage to 6th costal cartilage. On 
both the sides from the 6th costal cartilage pleura arches laterally and 
reaching the 8th rib in the midclavicular line, 10th rib in midaxillary line, 
12th rib lateral to levator spinae muscle. From here the pleura runs 
horizontally reaching the posterior midline at the level of T12 spine. 
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Intrapleural pressure 
Owing to the continual retractive force exerted by the elastic 
recoil of the lung, intrapleural pressure under normal conditions is 
negative. Elastic recoil of the lung is made up of three factors. 
1. The elastic tissue in the bronchial wall and also those coursing 
through out the interstitial tissue of the lung. 
2.The arrangement of the muscle fibres of the bronchioles in a 
“geodesic” network so that on contraction bronchial tree not only 
becomes reduced in diameter but also shortened in length 
3. The surface tension of the fluid lining the alveolar walls. 
Intrapleural pressure ranges from -5.6 mm of Hg on inspiration to                        
-2.6 of Hg on expiration. The pressure is less negative at the bottom than 
at the top of the lung. 
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Mechanism 
  Visceral pain is believed to be transmitted along afferent fibres 
from the abdominal viscera to the splanchnic nerves and also by the 
lower intercostal nerves which innervate the peritoneum. The lower 
intercostal nerves also supply the upper part of the abdominal wall. It is 
therefore important to block both the lower intercostal and splanchnic 
nerves in order to relieve postoperative   pain. 
 
  The intercostal space posteriorly has three layers.The external 
intercostal muscle, posterior intercostal membrane and the intercostalis 
intimus muscle. The intercostal nerves lie in between the posterior 
intercostal membrane and the intercostalis intimus muscle,whereas 
posterior intercostal membrane forms a complete barrier beneath the  
external intercostal muscle, the intercostalis intimus muscle is 
incomplete and freely allows fluid to pass in to the sub pleural space. 
Thus, interpleural analgesia can be accomplished by placing a catheter 
tip either deep to the internal intercostal muscle but superficial to the 
parietal pleura or between the parietal and visceral layers of pleura with  
concomitant multiple segmental intercostal nerve block.  
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The number of nerves affected depends on 
1. The level of the catheter  
2. The volume of anaesthetic injected  
3. Effects of gravity.  
 
  Diffusion of local anaesthetic from the pleural space seems to 
block several intercostal nerves simultaneously. The local anaesthetic is 
also believed to diffuse easily through the parietal pleural and this  
effectively blocks most of the intrathoracic sympathetic  chain including 
the splanchnic nerves. The blockade of both somatic and visceral pain 
fibres in interpleural block is an important distinction when compared 
with coeliac plexus block. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
27
 
 
Techniques 
 The "open chest" technique consists of insertion of an epidural 
type catheter via an epidural needle posterior and superior to the 
incision, the catheter being sutured at the skin, bacterial filter attached 
and sterile dressing applied. Infusion of the drug are not very effective 
with this method due to loss of injected drug through chest drain  tube. It 
will not be possible to clamp the chest drain for any length of time 
because of risk of pneumothorax in patients with an air leak.  
 
 In the "closed chest" technique a Tuohy needle and lubricated 
glass syringe are used. The needle is inserted at the sixth intercostal 
space, in the posterior axillary line, and walked off the superior border of 
the rib with its bevel directed towards the parietal pleura and its shaft 
parallel to the posterior path of the rib. Negative intrathoracic pressure 
causes sudden, dramatic loss of resistance, sucking the plunger of the 
syringe down as parietal  pleura is traversed. The syringe is then 
removed, with the thumb preventing further air entrainment and the 
catheter is advanced 6-10 cm.  
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Contraindications  
1. Pleural Effusion 
2. Pleural Adhesions and   fibrosis 
3. Injuries 
4. Bullous Emphysema 
5. Local infection  
6. Bleeding diathesis 
7. Recent pneumonia or pleuritis 
8. Cardiac arrythmias 
9. Convulsions 
10. Allergy to local anesthetics. 
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Complications 
Pneumothorax is a significant risk. Unilateral sympathetic block 
may be observed and can result in Horner’s syndrome. Chest wall 
hematoma is a possibility. Systemic absorption with significantly high 
plasma concentrations of local anaesthetics can be observed with 
continous infusions. Lung injurywith laceration or bronchopleural fistula 
formation are possible. Rarely local anaesthetic can spread to the 
epidural space and left recurrent laryngeal nerve palsy has been 
reported(13). 
 
Brismar (14) reported that four of 21 patients developed 
pneumothorax and one patient had the catheter placed extrapleurally. 
Seltzer et al (15) reported one case of seizure with a measured blood 
concentration of bupivacaine of 4.9 ng / ml at 5 min after injection. 
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Clinical assessment of pain  
Postoperative pain severity can be scored and recorded .Pain 
severity scores cannot be viewed in isolation .They should be considered 
along with traditional ward observations of pulse rate, blood pressure 
and respiratory rate .Such recording most likely to improve the safety 
and effectiveness of pain management. 
The simple pain scoring systems are  
1. Categorical rating scales(CRS) 
Frquently used to assess postoperative pain because it is easy verbal 
method that can employ different descriptors of pain. 
e.g –No pain, mild pain, moderate pain, severe pain. 
2. Visual analogue scale (VAS) 
Employs 10 cm drawn line with the left anchor point descriptor labeled 
“No pain” and right sided equivalent labelled “worst possible pain” 
3. Verbal numerical rating scale (VNRS) 
Patients are asked to estimate their pain severity as a number “0” being 
no pain, and “10” being worst possible pain. 
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Visual analogue scale (VAS) 
The VAS is a simple and sensitive assessment that is often used to 
measure and study a patient’s pain .Its usefulness has been validated by 
several investigators. A VAS has been found to be superior to fixed 
interval scales, relative pain scales, and verbal reports of pain. Subjects 
simply place a mark on a 10cm line   anchored with the terms describing 
the extremes of pain intensity. It is often used in the immediate post-
operative period to determine the effects of analgesics and/or pain 
management regimens.  
The VAS had been adapted for pediatric populations by substitution  
pictures of  faces ranging from agony to happiness and is termed   the  
Faces Pain Scale. 
 
 
Categorical Scale 
None (0) Mild (1-3) Moderate (4-6) Severe (7-10) 
 
           
 
0 1 2 3 4 5 6 7 8 9 10 
No pain                   
Worst 
pain 
imaginable
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Pain Faces Scale 
 
   
0 
Very happy, 
no hurt 
2 
Hurts just a 
little bit 
4 
Hurts a little 
more 
6 
Hurts even 
more 
8 
Hurts a 
whole lot 
10 
Hurts as 
much as you 
can imagine 
(don't have 
to be crying 
to feel this 
much pain) 
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Drugs 
Pentazocine 
 Pentazocine is a benzomorphan derivative that possesses 
opiod agonist as well as weak antagonist action. It is presumed to exert 
its effects at delta and Kappa receptors. 
Pharmocokinetics 
 Pentazocine is well absorbed after oral or parentral 
administration .First pass hepatic metabolism is extensive .Oxidation of 
the terminal methyl groups results in inactive glucronide conjugates 
which are excreted in the urine. Upto 25% of the administered dose 
excreted unchanged in urine .Elimination half time is 2 to 3 hours. 
Dose 
 Pentazocine 10 to 30 mg IV or 50 mg orally is used most 
often for relief of pain . 
Side effects 
 Most common side effects of pentazocine is sedation, 
diaphoresis and dizziness. Nausea and vomiting are less common .It 
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produces increase in the plasma concentrations of the catecholamines 
,which may account for increases in the heart rate,blood pressure 
pulmonary artery pressure and left ventricular end diastolic pressure. 
 The increase in biliary tract pressure is least common with 
pentazocine. Increasing the parenteral dose does not increase the 
ventillatory depression. 
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Structural Formula - PENTAZOCINE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CH3 
HO 
H3C NCH2CH        C    
CH3 
CH3 
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Bupivacaine  
This belongs to amide group of local anaesthetics which contain 
asymmetric carbon atom.  
Mechanism of action  
Bupivacaine binds to sodium channels in the inactivated –closed 
state resulting in inhibition of sodium permeability and hence 
conduction of nerve impulses in the form of propagated action potential 
cannot occur. 
Pharmacokinetics 
Absorption of bupivacaine from its site of injection in to systemic 
circulation is influenced by site of injection and dosage, use of 
epinephrine and pharmacological characteristics of the drug. 
After rapid entry of bupivacaine in to venous circulation pulmonary 
extraction occurs which limits the concentration of the drug reaching the 
systemic circulation. In addition to the tissue blood flow and lipid 
solubility of the drug, the patient related factors such as age 
cardiovascular status and hepatic function will also influence the 
absorption and resultant plasma concentration .Protein binding of the 
drug will influence the distribution and excretion .Clearance values and 
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elimination half times represent mainly the hepatic metabolism, because 
renal excretion of unchanged drug is minimal ( < 5 %). 
Dose 
2mg/kg upto maximum of 175 mg .Duration lasts upto 240 to 480 
minutes. 95% of the drug is bound to the alpha1 acid glycoprotein in the 
plasma. Volume of distribution is 73 litres. It is metabolized by the 
aromatic hydroxylation, N-dealkylation, amide hydrolysis and 
conjugation.Clearance rate is 0.47litres /Min. The measured total urinary 
excretion of bupivacaine and its dealkylation and hydroxylation 
metabolites account for more than 40% of the total anaesthetic dose. 
 
Side effects 
    Allergic reactions are less common than the ester group of local 
analgesics. Important complications include systemic toxicity which 
depends on  
1. Dose 
2.Vascularity of injection site. 
3. Presence of epinephrine 
4. Physiochemical   properties  
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CNS Toxicity 
 
     Low concentration is characterized by characterized by numbness of 
the tongue and circumoral areas. As the plasma concentration continues 
to increase bupivacaine readily crosses the blood brain barrier and 
produce predictable pattern of CNS change. Restlessness, tinnitus, 
vertigo occur initially. Further increase in CNS concentration results in 
slurred speech and twitching .Finally tonic clonic seizures occurs which 
is classically followed by hypotension and apnea. The onset of seizures 
may reflect selective depression of inhibitory cortical neurons by local 
anaesthetic leaving excitatory pathways unopposed. 
 
The typical plasma concentration of bupivacaine associated with 
seizures is 4.5 to 5.5 microgram/ml. 
Treatment of Seizures  include ventilation of patients lung with oxygen 
to prevent arterial hypoxemia and metabolic acidosis. Delivery of 
supplemental oxygen at the earliest sign of local anaesthetic toxicity is 
equally important. Intravenous administration of benzodiazepine is 
effective in suppressing local anaesthetic induced seizures. 
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CVS toxicity 
 
   Accidental intravenous injection of bupivacaine may result in 
precipitous hypotension cardiac dysarrythmia and atrioventricular block.   
It is due to prolonged blockade of cardiac sodium channels .The 
threshold for cardiactoxicity produced by bupivacaine may be decreased 
in patients treated with  drugs such as beta adrenergic blockers, digitalis, 
calcium channel blockers .This suggests that bupivacaine should be used 
with caution when concomitant cardiac medications known to depress 
the myocardial impulse propagation. 
Epinephrine and phenylephrine may increase bupivacaine 
cardiotoxicity owing to inhibition of cyclic CAMP production. 
Dissociation of highly lipid soluble bupivacaine from sodium channel 
receptors site is slow, accounting for the drugs persistent cardiac 
depression. Tachycardia can enhance frequency dependent blockade of 
cardiac sodium channels by bupivacaine. The plasma concentration of 
bupivacaine associated with cardiovascular toxicity is 8 to 10 
microgram/ml. 
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Treatment 
It consists of intravenous administration of bretylium 20 mg/kg 
which reverses bupivacaine induced cardiac depression and increases the 
threshold for ventricular tachycardia. 
 
Ventilatory response to hypoxia 
Unlike other local anaesthetics systemic absorption of bupivacaine 
such as following peripheral nerve block stimulates the ventilatory 
response to carbondioxide. 
 
 
Preparations 
0.5% solution 20 ml vial with sodium metabisulphite as preservative. 
0.5 % solution 4 ml ampoule without preservative for intrathecal use. 
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PATIENTS AND METHODS 
 
         After approval from local ethics committee and written informed 
consent 36 patients undergoing elective upper abdominal surgeries like 
open cholecystectomy, nephrectomy , pyelolithotomy and pyeloplasty at 
Government General Hospital, Chennai were enrolled in the study. The 
inclusion criteria were age 19 to 65 years ASA   physical status  1 & 2 
with no contraindications for the technique and drugs. These include 
pleural injury, pleural adhesion, fibrosis or effusion, COPD, local 
infection, bleeding diathesis and allergy to study drugs.  The linear 
visual analog scales (VAS) were explained to the patients prior to the 
study.  
 
Patients were premedicated with Inj glycopyrrolate 0.2mg and Inj 
fentanyl 100 micrograms IV just before induction. Patients were induced 
with Inj propofol 2mg /Kg, Inj Suxamethonium 100mg IV and intubated 
one minute later with appropriate size endotracheal tube orally. The 
anaesthesia was maintained with nitrous oxide – oxygen mixture 3:2, 
muscle relaxant Inj Vecuronium and volatile agents.  
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When the surgery was over the patients were randomly assigned 
to two trearment groups of 18 patients in each. 
1) Pleural analgesia (bupivacaine) combined with Parenteral analgesics 
(Pentazocine). 
2) Parenteral analgesics alone. (Pentazocine) 
 
In patient assigned in pleural group the catheter was inserted 
unilaterally on the  side of incision. The patients were positioned 
laterally with operative site up and pleural catheter was inserted at the 
sixth intercostal space in the posterior axillary line just before 
anaesthesia was discontinued during spontaneous ventilation. Intercostal 
drainage tube was kept ready throughout the study period to manage any 
untoward pneumothorax  occurence.. 
 
Under aseptic precautions the 17 G Tuohy needle loaded with 5ml 
syringe containing normal saline introduced in the sixth intercostal space 
and then walked off the superior edge of the rib. The loss of resistance to 
saline technique was used to identify the entry in to the pleural cavity. 
The catheter was then advanced posterosuperiorly   past the tip of the 
needle and fixed in position close to the  paravertebral space and the  
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Position for interpleural block 
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needle is withdrawn. Forty milliliters of Injection bupivacaine 0.25%, 
was injected through catheter after negative aspiration for blood. Patient 
was turned supine and after reversal extubated. 
In patients in control group no analgesics were given before extubation. 
 One hour after extubation and every 6 hrs thereafter in   both the groups 
pain was recorded using Visual analog scale (VAS). The patients were 
given pain relief medication on demand . In the control group patients 
were given Inj Pentazocine 30 mg intramuscularly .In the pleural group 
break through pain was treated similiarly. 
 Postoperatively, one hour after pleural puncture chest radiograph 
was obtained for detection of a possible pneumothorax in pleural group.  
Pain was evaluated with a 10 cm VAS in both the groups. Patients were 
continuously monitored with ECG. Blood pressure and heart rate were 
recorded noninvasively every 5 minutes up to 30 minutes after the bolus 
in both groups.  
The total parentral analgesic requirement in the initial 48 hrs 
postoperative period was recorded. The study was stopped after 48 hours 
because of concerns of the interpleural catheter displacement following 
mobilization of the patient and fear of catheter-related infection.  
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Statistical Analysis 
Student t test was used to compare the pentazocine requirement and 
VAS scores between the pleural and control groups. 
Data was analyzed with SPSS software.  
Data are presented as means ± SD. The P values were provided to 
indicate statistical significance. P < 0.05 was considered as significant. 
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RESULTS 
 
 One patient was  excluded from the study due to aspiration of blood in 
the pleural catheter. Demographic data were similar in both the groups 
(Table 1). Mean age was 40.7yrs ± 11.30 (21 to 56 yrs) in pleural group 
and 44.6 yrs ± 11.9 (18 to 65 yrs) in control group. No episodes of 
hypotension or bradycardia were noted. Neither pneumothorax nor CNS 
(central nervous system) toxic reactions (tremor, perioral numbness, 
muscle twitches, metallic taste, tinnitus,convulsions) were noted. The 
catheter insertion using loss of resistance technique described above was 
easy to identify the pleural space and effective.   
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Table 1: Patient characteristics  
 Pleural  
Group(18) 
Control 
group(18) 
Age(yr) 40.7 ± 11.3  44.2 ± 11.9 
Sex(male/female) 5/12 10/8 
Weight(Kg) 55.4 ± 5.9 57 ± 6.8 
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The consumption of pentazocine (table 2) was analyzed. Daily  
 
consumptions of  pentazocine were higher in control group than in  
pleural group, for Day 1(P < 0.001), Day 2 (P < 0.01) and Day1 + 2 
 (P <0.001) and was significant. It was found that difference was more  
significant on Day 1. Patients of control group received a mean dose  
of 114.9 ± 20.7 mg of pentazocine in the first 48 hrs postoperatively 
in contrast to pleural group which received mean dose of 61.6 ±8.7 mg. 
 
 
 
 Table 2: Pentazocine consumption (mg) in the two groups recorded at 
Days 1 and 2 postoperatively and during whole study period 
 (Day 1 + Day 2) 
Group Day1 Day 2 Day1+ 2 
Pleural  33.3  ± 9.7 28.3 ± 7.0 61.6 ±   8.7 
Control  68.3 ± 13.8 46.6 ± 21.1 114.9 ± 20.7 
P Value < 0.001 < 0.01 < 0.001 
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BAR DIAGRAM SHOWING PENTAZOCINE CONSUMPTION    
IN PLEURAL & CONTROL GROUP 
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Mean pain scores were significantly reduced 30 min after IP 
instillation of bupivacaine 0.25 % compared to control group . The mean 
pain score of the pleural group is 2.96 ± 0.72   and mean  pain score of 
the control group is 6.04 ± 1.30 for 48 hrs.     
 
There was significant difference between the groups when 
comparing mean pain scores (P <0.001). When VAS scores were 
analyzed at each time point recorded   showed   significant difference 
between the groups at any time of measurement (Table 3.) 
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Table 3 Pain scores   
Time Interpleural 
Pain score 
Control  
Pain score 
P Value 
1 Hour 4.0± 1.2 7.8  ± 0.7 < 0.001 
6 Hour 3.6 ± 0.8 7.7 ± 0.7  < 0.001 
12 Hour 3.5 ±1.0 7.0 ± 1.0 < 0.001 
18 Hour 3.1 ± 1.3 6.3 ± 1.0 < 0.001 
24 Hour 3.0 ± 1.4 5.8 ± 1.3 < 0.001 
30 Hour 2.8 ± 1.4   5.5 ± 1.2 < 0.001 
36 Hour 2.4 ± 1.1 5.0 ± 1.2  < 0.001 
42 Hour 2.1± 1.2 4.4 ± 1.2 < 0.001 
48 Hour 1.8 ± 1.1 4.4 ± 1.1 < 0.001 
Total(48 hrs) 2.96 ± 0.72  6.04 ± 1.30 < 0.001 
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Visual analogue scale (VAS) pain score versus time in patients assigned 
to pleural bupivacaine (♦) or  control group (■). Data are presented as 
mean ± SD.  
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Discussion 
  
The aim of postoperative pain management is to provide good 
subjective comfort and to contribute to early recovery and a good 
outcome after  surgery. 
 In this prospective study we have investigated the efficacy of 
intermittent boluses of interpleural bupivacaine compared to 
intramuscular pentazocine with regard to postoperative pain relief. Many 
clinicians avoid the closed chest technique for the placement of an 
interpleural catheter because of the high incidence of pneumothorax (3).  
Using our technique, pneumothorax was not seen in our patients as 
determined by chest x-ray in the recovery room. We used a syringe filled 
with saline and a Touhy needle instead of a lubricated glass syringe to 
locate the interpleural space. This may eliminate false negatives caused 
by sticking between the piston and the syringe wall and thus prevent the 
needle from being accidently advanced too   far into the thoracic cavity. 
Our technique is equally effective as the balloon method and it was easy 
to identify the pleural space. 
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We used pentazocine for comparison with interpleural 
bupivacaine because it has less propensity for causing spasm of 
spinchter of Oddi . 
The intramuscular route was chosen because of the simplicity of 
 administration by nurses in the post operative ward. 
Nevertheless, the use of interpleural local anesthetics is not devoid of 
side effects that include pneumothorax ( most common ), systemic 
toxicity of local anesthetics, pleural effusion, Horner's syndrome, pleural 
infections, catheter rupture, and temporary phrenic nerve palsy (16,17). 
No such complications were recorded in our patients. Pneumothorax and 
phrenic nerve palsy were excluded in our patients by   chest X-rays. 
Furthermore, the use of a diluted local anesthetic solution decreased the 
propensity for phrenic nerve palsy and toxic reactions. 
Parenteral   opiods are similarily associated with risks, especially 
ventillatory depression and cognitive impairment that may restrict early 
postoperative ambulation.There is significant opiod sparing  benefit by 
the interpleural analgesia. 
We have   chosen 40 ml of 0.25% bupivacaine every 6 hrs because this 
dose is unlikely to be associated with toxic plasma concentration.(18) 
In fact, postoperative alpha l-acid-glycoprotein increases, leading to  
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an increase in protein binding of local anesthetics and to a reduction 
 
 of free-fraction, thus diminishing the risk of potential central  
 
nervous system toxicity (19). Moreover, Scott (20) suggests that the  
absolute toxic plasma concentration may be more dependent on the  
rate of increase of the concentration than on any exact concentration 
of bupivacaine. 
Von Kleef et al also found no difference between the use of 0.5% and 
0.25% bupivacaine for interpleural analgesia (21).We used 0.25% 
bupivacaine which produced effective analgesia. 
The quality of analgesia obtained in our study is consistent with that 
reported by others.(2,3,4). 
The results of this study demonstrate the effective analgesia obtained  
in the immediate postoperative period by the injection of interpleural 
 bupivacaine after upper abdominal  surgery. 
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CONCLUSION 
It is concluded from this study that intermittent interpleural 
analgesia with bupivacaine was more effective than intermittent 
parenteral administration of pentazocine alone , in reducing the severity 
of pain after upper abdominal surgery up to 48 hours postoperatively and 
can be recommended for sufficient pain control. 
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Pleural analgesia– PROFORMA 
 
DEPARTMENT OF Anaesthesiology 
GOVERNMENT GENERAL  HOSPITAL, CHENNAI-01. 
 
 
       
                        Sl.No:                                                            Date :  
                              
                         I.P.NO                               
 
                       
 
                          
          NAME:                                                                              AGE:             
SEX:  
                                                                     
 
    Diagnosis:                                                                 D.O.O:                   
 
Surgery : 
 
 
ASA  PS :  1    2                                                Allergy to study drugs: 
yes/No 
    
 
 WEIGHT:                                                         Consent  
                           
                      
                       
 
 
Methods : General anaesthesia with IPPV 
Premedication :  
                         Inj Glycopyrrolate 0.2 mg IV 
                         Inj Fentanyl 100 mic   IV 
Induction :       Injpropofol   
                         Inj Succinyl choline  
                          
Intubation:     
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Maintainence:   
 
Pleural catheter placement: 
 
Drug  
 
 
 
 
Extubation 
 
 
 
 
Timings  pulse BP RR VAS Pneu 
mothor
ax  
Toxicity Additio
nal 
 
 
Time 
 analgesia 
 
 
 
Drug  
1Hr         
6Hr         
12Hr         
18Hr         
24Hr         
30Hr         
36Hr         
42 Hr         
48Hr         
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Numerical Scale 
           
 
0 1 2 3 4 5 6 7 8 9 10 
No pain                   
Worst
pain 
imaginable
 
Visual Analog Scale 
No 
pain  
Worst
pain
  
Directions: Ask the patient to indicate on the line where the pain is in 
relation to the two extremes. Qualification is only approximate; for 
example, a midpoint mark would indicate that the pain is 
approximately half of the worst possible pain. 
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Categorical Scale 
None (0) Mild (1-3) Moderate (4-6) Severe (7-10) 
Pain Faces Scale 
   
0 
Very happy, 
no hurt 
2 
Hurts just a 
little bit 
4 
Hurts a little 
more 
6 
Hurts even 
more 
8 
Hurts a 
whole lot 
10 
Hurts as 
much as you 
can imagine 
(don't have 
to be crying 
to feel this 
much pain) 
 
 
  
    
Time of catheter removal  
 
 
Remarks. 
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SNO NAME AGE(yr) SEX POD1(mg) POD(2) VAS:1HR 6HR 12HR 18HR 24HR 30HR 36HR 42HR 48HR SIDE surgery Weight(kg) 
1 Selvam 36 M 30 30 5 5 5 5 5 4 4 4 2 0 Neph 55 
2 parvathy 46 F 60 30 3 3 4 4 4 4 1 1 1 0 Py.plas 45 
3 amaravathy 29 F 30 0 5 4 3 3 3 2 2 2 1 0 Py.plas 52 
4 raji 28 F 60 30 4 3 4 3 3 3 2 2 2 0 Py.plas 45
5 valliammal 52 F 30 30 2 3 2 2 2 2 2 1 1 0 Neph 56 
6 sornam 56 F 30 30 4 4 4 5 4 4 3 3 3 0 Neph 60 
7 govindamal 45 F  30 30 4 3 3 2 2 1 1 1 1 0 Py.Lith 70 
8 morkayee 46 F  30 30 4 4 4 3 2 2 4 3 3 0 Neph 55 
9 amirtham 56 F  30 30 5 4 4 4 3 2 2 1 1 0 Neph 59 
10 varalakshmi 36 F  30 30 4 3 3 1 1 1 2 1 1 0 Py.plas 52 
11 vellathai 50 F  30 30 4 4 2 2 2 2 2 1 1 0 Chole 60 
12 sampath 40 M 30 30 5 4 4 4 5 5 3 3 3 0 Chole 55 
13 chinnaponnu 38 F  30 30 3 3 5 4 4 4 4 3 3 0 Chole 60 
14 ramamorthy 47 M 30 30 4 5 4 4 3 3 2 2 2 0 Py.Lith 55 
15 selvakumar 27 M 30 30 3 3 3 1 1 1 1 1 1 0 Py.plas 55 
16 saraswathy 21 F  30 30 2 2 1 1 1 1 1 1 1 0 Py.plas 48 
17 baskaran 25 M 30 30 5 5 4 4 5 5 5 5 5 0 Chole 60 
18 vijyakumari 55 M 30 30 7 4 4 4 5 5 3 3 2 0 Chole 56 
MASTER CHART – PLEURAL GROUP 
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SNO NAME AGE(yr) SEX POD1(mg) POD2(mg) VAS:1HR 6HR 12HR 18HR 24HR 30HR 36HR 42HR 48HR SIDE surgery Weight(kg) 
1 pitchai 65 M 90 60 9 8 8 7 7 7 7 6 5 0 Py.plas 50 
2 chandraiya 45 M 90 90 9 8 8 7 7 7 6 6 6 0 Neph 60 
3 arumugham 46 M 90 60 8 8 7 7 7 7 6 6 5 0 Py.Lith 55 
4 paramasivam 46 M 60 60 7 6 5 4 4 2 2 2 2 0 Py.Lith 60 
5 nisi 18 F 90 90 9 9 8 5 8 5 5 2 4 0 Py.Lith 50 
6 thirupal 46 F 60 60 8 8 6 6 5 5 4 4 3 0 Py.Lith 55 
7 rajamani 50 F 60 30 7 7 6 6 5 5 4 4 4 0 Py.plas 50 
8 banumathi 35 F 60 30 9 8 9 7 5 5 4 4 4 0 Py.Lith 50 
9 ramakrishnan 37 M 60 30 8 7 7 6 8 6 5 5 5 0 Py.Lith 52 
10 venkatesh 38 M 60 30 8 8 7 7 6 6 6 5 5 0 Py.plas 75 
11 kalaiselvi 48 F 60 30 8 8 7 7 6 6 5 5 5 0 Chole 60 
12 malini 46 F 60 30 7 8 8 7 6 6 6 4 4 0 Chole 65 
13 hamsaveni 48 F 60 30 7 7 6 6 4 5 5 4 4 0 Chole 60 
14 sekar 45 M 90 60 7 7 6 5 5 5 5 4 4 0 Py.Lith 55 
15 lakshmanan 62 M 60 30 7 8 8 7 5 5 4 4 4 0 Neph 60 
16 babu 40 M 60 30 8 8 7 7 7 7 6 6 7 0 Py.plas 52 
17 kamsan 60 M 60 60 8 7 6 5 4 4 4 3 3 0 Py.Lith 66 
18 kalaiselvi 22 F 60 30 8 9 8 8 7 7 7 6 6 0 Py.Lith 52 
 
 
MASTER CHART – CONTROL GROUP 
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